Eva Goetz is a highly motivated scientist with over ten years of research experience in cell and molecular biology, focusing on oncology and cell signaling. In their previous position, they conducted a pooled cDNA screen that led to a publication in *Cancer Research*. Currently, Eva investigates in vitro dosing strategies for MAPK inhibitor combinations to prevent drug resistance. Their background includes significant mentorship roles during their PhD and postdoc, as well as collaborative projects focused on validating mechanisms of resistance in cancer. Eva's work contributes to the development of rational drug combinations and strategies for targeted cancer therapies.
This person is not in any teams
This person is not in any offices